NDC 50090-6089-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6089
- Requested NDC
- 50090-6089-01
- Package NDCs from labels
- 50090-6089-0, 50090-6089-1, 50090-6089-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6089-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-6089-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6089 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6089-0 | EA - Each | 50090-6089 | 1b7b2683-840d-46d0-917e-a7d77279de70 | 1 | 2022-10-06 |
| 50090-6089-1 | EA - Each | 50090-6089 | bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Oxide | MAGNESIUM OXIDE | Richmond Pharmaceuticals, Inc. | 9119b7f0-3e8a-7be7-e053-2995a90a4634 | 2024-12-26 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Richmond Pharmaceuticals, Inc. | db5941b2-0a04-452a-8fbc-bd5e40fadfb1 | 2024-12-26 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 27e98e6d-9fd7-3a94-e063-6394a90a1dcb | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 576dcd01-d151-42ac-acd1-480a13bae176 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966220 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals,Inc. | 29bb8dbe-f8ba-e2ba-e063-6394a90af38c | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a0ffe111-3574-4481-a732-b68a7d58ef71 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a55e735f-a5b0-4b85-9fd7-3a4b6723a81b | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 893f9d10-7ce5-4ae6-8f03-dfde35ca6c30 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f23cacf6-0509-4e6b-bb59-6f1c17b16411 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 6edb9499-b869-4ec8-82d7-56d267fd3dec | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 2ee67e24-d72f-4419-a7d2-95bb44d9dd26 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892251 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | b57d0cc5-9fc7-496a-9bfa-417a288bb825 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966248 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 68a6702d-ca0b-4e04-88a6-4accc8fb459e | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e1f77539-2156-4890-baca-8b13779c745c | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Amneal Pharmaceuticals NY LLC | fca88c97-5cd4-4834-ba87-deb5bd637788 | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| Ventrixyl | FOLIC ACID | PureTek Corporation | c29dc729-93be-2a20-e053-2a95a90a8ca3 | 2024-12-03 | Warnings, Adverse reactions | 3A3U0GI71G |
| Folitin-Z | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb141ac2-e5df-4df4-e053-2995a90a6e72 | 2024-12-02 | Warnings, Adverse reactions | 3A3U0GI71G |
| Foliflex | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | cba98d1a-8cf9-39d9-e053-2995a90ae8bb | 2024-11-27 | Warnings, Adverse reactions | 3A3U0GI71G |
| Finazol | FERROUS FUMARATE, FOLATE | PureTek Corporation | 24290823-022a-433b-e063-6394a90a8fd0 | 2024-11-07 | Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 2646a481-09a5-af6a-e063-6394a90a16da | 2024-11-06 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.